Reconstituted fresh whole blood improves clinical outcomes compared with stored component blood therapy for neonates undergoing cardiopulmonary bypass.

Slides:

Advertisements

Similar presentations

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Advertisements

Manuel J. Antunes, MD, PhD, DSc

Stephen R. Broderick, MD, MPHS

David W. Barbara, MD, William J. Mauermann, MD, James R

Risk factors for neurodevelopmental impairments in school-age children after cardiac surgery with full-flow cardiopulmonary bypass Michael von Rhein,

Rounding numbers The Journal of Thoracic and Cardiovascular Surgery

The impact of frailty on outcomes after cardiac surgery: A systematic review Aresh Sepehri, BSc, Thomas Beggs, Ansar Hassan, MD, PhD, FRCSC, Claudio Rigatto,

Insulin resistance and inflammation are a cause of hyperglycemia after pediatric cardiopulmonary bypass surgery Alejandro A. Floh, MD, Cedric Manlhiot,

Improving health care by embracing Systems Theory

Neel R. Sodha, MD, Frank W. Sellke, MD

Building a bioartificial heart: A 3-song saga

Ground glass opacity of the lung: The veil that needs lifting

Bahaaldin Alsoufi, MD, Cedric Manlhiot, BSc, William T

Derrick Y. Tam, MD, Stephen E. Fremes, MD, MSc, FRCSC, FACP, FACC

Intrinsic cardiac stem cells are essential for regeneration

Victor van Berkel, MD, PhD

How should we treat air leaks?

Definition of postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass: One size doesn't fit all David Faraoni, MD,

Harold L. Lazar, MD The Journal of Thoracic and Cardiovascular Surgery

Survival outcomes after rescue extracorporeal cardiopulmonary resuscitation in pediatric patients with refractory cardiac arrest Bahaaldin Alsoufi, MD,

The lord of the rings Antonio Miceli, MD, PhD

Certification in cardiothoracic surgical critical care: A distinction for some or for all? Nicholas D. Andersen, MD The Journal of Thoracic and Cardiovascular.

Cardiothoracic surgical critical care surgeons: Many of the few

Is tissue the issue? Brian E. Louie, MD, MHA, MPH, FRCSC, FACS

Randomized trial of hematocrit 25% versus 35% during hypothermic cardiopulmonary bypass in infant heart surgery Jane W. Newburger, MD, MPH, Richard A.

Conduit conundrum: If not two, why three?

Profiles of hemodynamics and oxygen transport derived by using continuous measured oxygen consumption after the Norwood procedure Jia Li, MD, PhD, Gencheng.

Juan N. Pulido, MD The Journal of Thoracic and Cardiovascular Surgery

Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity Cedric Manlhiot, PhD, Colleen.

Disruption of the ventricular myocardial force-frequency relationship after cardiac surgery in children: Noninvasive assessment by means of tissue Doppler.

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Military surgeons just want to have fun

Do we need a bibliometrician to know which way the wind is blowing?

A first start for lung transplantation?

The influence of hemodilution on outcome after hypothermic cardiopulmonary bypass: results of a randomized trial in infants Richard A Jonas, MD, David.

“Reverse Blalock-Taussig shunt”: Application in single ventricle hybrid palliation Kenji Baba, MD, PhD, Osami Honjo, MD, Rajiv Chaturvedi, MD, PhD, FRCPC,

Niv Ad, MD, Sari D. Holmes, PhD, Paul S. Massimiano, MD, Anthony J

Stephen R. Broderick, MD, MPHS

The effects of normoxic versus hyperoxic cardiopulmonary bypass on oxidative stress and inflammatory response in cyanotic pediatric patients undergoing.

Commentary: Faster recovery after complex neonatal cardiac surgery

Replicating the success of mitral valve repair in the aortic valve

A fate worse than death Jennifer S. Lawton, MD

Commentary: Points to ponder—Perioperative antithrombotic therapy in neonates with congenital heart disease…more harm than good? Mary Patricia Massicotte,

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Using bilateral internal thoracic arteries—just do it

Patients with unbalanced atrioventricular canal defects can undergo the Fontan operation with good outcomes Sitaram M. Emani, MD The Journal of Thoracic.

Ralph S. Mosca, MD The Journal of Thoracic and Cardiovascular Surgery

Innovation in cardiothoracic surgical training

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

Bryan M. Burt, MD The Journal of Thoracic and Cardiovascular Surgery

Early extubation after cardiac surgery: The evolution continues

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Finding the sweet spot: Titrating unfractionated heparin in children after cardiac surgery to prevent thrombosis and minimize bleeding Leslie Raffini,

Should it stay or should it go?

After neoadjuvant chemoradiation therapy, predicted pulmonary function may be reduced by 10% Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular.

“The more things change…”: The challenges ahead

First in line for robotic surgery: Would you want to know?

Ryan R. Davies, MD The Journal of Thoracic and Cardiovascular Surgery

Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery Raja M. Flores, MD The Journal.

Repetition is the mother of skill

Preoperative PFTs: The answer is blowing in the wind

The evolution of cardiothoracic critical care

Sunjay Kaushal, MD, PhD, Brody Wehman, MD

The Journal of Thoracic and Cardiovascular Surgery

Journal changes and initiatives

Redosing antibiotics during cardiopulmonary bypass: The time is now

Deciding how much to pay for effective care

Presentation transcript:

Reconstituted fresh whole blood improves clinical outcomes compared with stored component blood therapy for neonates undergoing cardiopulmonary bypass for cardiac surgery: A randomized controlled trial Colleen E. Gruenwald, MHSc, RN, CCP, CPC, Brian W. McCrindle, MD, MPH, Lynn Crawford-Lean, BSc, RRT, CCP, CPC, Helen Holtby, MD, Christopher Parshuram, MBChB, D Phil, Patricia Massicotte, MSc, MD, FRCPC, MHSc, Glen Van Arsdell, MD The Journal of Thoracic and Cardiovascular Surgery Volume 136, Issue 6, Pages 1442-1449 (December 2008) DOI: 10.1016/j.jtcvs.2008.08.044 Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Serial laboratory measurements. Only laboratory variables that showed a significant interaction between intervention assignment and time period are shown. Data presented are least square means with the error bar representing the standard error of the mean, derived from mixed linear regression analysis adjusted for repeated measures, with only significant P values reported from the multivariable analysis. ∗P < .05. ACT, Activated clotting time; CCCU, cardiac critical care unit; CPB, cardiopulmonary bypass. The Journal of Thoracic and Cardiovascular Surgery 2008 136, 1442-1449DOI: (10.1016/j.jtcvs.2008.08.044) Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions